IMMUNOGLOBULIN G1, ANTI-(HUMAN CA125 (CARBOHYDRATE ANTIGEN)) (MOUSE MONOCLONAL B43.13.GAMMA.1-CHAIN), DISULPHIDE WITH MOUSE MONOCLONAL B43.13.KAPPA.-CHAIN, DIMER
Peritoneal Carcinoma
CanariaBio Inc.monoclonal_antibodyPhase 3Active
B
56/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 41/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Peritoneal Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin CanariaBio Inc. | Phase 3 | BB |
STAPULDENCEL SOTIO a.s. | Phase 3 | B |
Eloxatin University of Utah | Phase 2 | B |
Interferon Gamma-1B InterMune | Phase 3 | B |
Arimidex Massachusetts General Hospital | Phase 2 | B |
View all 18 →
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN CA125 (CARBOHYDRATE ANTIGEN)) (MOUSE MONOCLONAL B43.13.GAMMA.1-CHAIN), DISULPHIDE WITH MOUSE MONOCLONAL B43.13.KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →